1 Antagonistic properties of OPC-28326 ([4-(N-methyl-2-phenylethylamino)-1-(3,5-dimethyl-4-propionyl-aminobenzoyl)] piperidine hydrochloride monohydrate), a selective peripheral vasodilator, were investigated by analysing the data from functional studies in various tissues from the rat and binding studies of the drug to a 2 -adrenoceptor subtypes. 2 Using a human recombinant receptor and rat kidney cortex, we found that OPC-28326 displays a nities to a 2A -, a 2B -and a 2C -adrenoceptors with K i values of 2040, 285, and 55 nM, respectively. The K i values of yohimbine for a 2A -, a 2B -, and a 2C -adrenoceptors were 3.0, 2.0 and 11.0 nM, respectively. 3 B-HT 920, an a 2 -adrenoceptor agonist, produced a pressor response via peripheral postsynaptic a 2 -adrenoceptor stimulation (thought to be an a 2B -subtype) in a reserpine-pretreated pithed rat preparation. OPC-28326 (3 ± 30 mg kg 71 , i.v.) and yohimbine (0.3 ± 3 mg kg 71 , i.v.) caused dosedependent rightward shift in the pressor dose-response curve induced by B-HT 920. The apparent pA 2 values were 1.55 (0.87 ± 2.75, 95% con®dence interval) and 0.11 (0.06 ± 0.21) mg kg 71 , respectively. The potency of OPC-28326 was about 14 times less than that of yohimbine. 4 Clonidine inhibited the tension developed by electrical stimulation, of the rat vas deferens, by its peripheral presynaptic a 2A/D -adrenoceptor action. OPC-28326 (1 ± 100 mM) and yohimbine (10 ± 1000 nM) caused a rightward shift in the concentration-response curve of clonidine. The pA 2 values were 5.73 (5.54 ± 5.91) and 7.92 (7.84 ± 8.01), respectively, providing evidence for a potency of OPC-28326 of about 155 times less than that of yohimbine. 5 Mydriasis was induced by brimonidine via stimulation of central a 2A/D -adrenoceptors in anaesthetized rats. Intravenous OPC-28326 had no e ect on this action, even at a very high dose of 10 mg kg 71 i.v., while yohimbine (0.1 ± 0.3 mg kg 71 i.v.) inhibited mydriasis in a dose-dependent manner, indicating that OPC-28326 was at least 100 times less potent than yohimbine in regard to the anti-mydriatic e ect. 6 These data suggest that OPC-28326 preferentially exerts peripheral and postsynaptic antagonistic actions on the a 2B -and a 2C -adrenoceptor subtypes.